His keynote lecture, in particular, provided insight into the latest advancements in treating corneas that are less than 400 microns thick – and potentially as low as 200 microns, using the sub400 protocol.
The success of SMILE procedures depends not only on the expertise of the surgeon but also on the ability to correct any complications that may arise. Prof. Hafezi’s article provides insight into the various approaches available for repairing failed SMILE procedures. Corneal wavefront-guided transPRK stands out as a method that offers significant advantages, including improving the corneal biomechanics and avoiding postoperative ectasia.
Prof. Farhad Hafezi, MD, PhD, FARVO, a prominent Swiss eye surgeon and researcher, has been awarded the title of “KOL Influencer 2023” by Media Mice,
A recent study has identified the most cited articles and authors in refractive surgery using the Scopus database and a publicly available database of over 100,000 scientists. The study provides a comprehensive analysis of the most highly cited articles and authors in refractive surgery, shedding light on the significant contributions of researchers and physicians to the field. ELZA’s Medical Director, Prof. Farhad Hafezi, was one of the top 100 cited authors. Find out more about the study and the top contributors in refractive surgery.
Prof. Farhad Hafezi, MD, PhD, FARVO is the Medical Director at The ELZA Institute, was recently interviewed by Ocular Surgery News (OSN), where he spoke about advancing CXL technology for the treatment of corneal ectasias like keratoconus. The interview covered three main topics.
An article by Prof. Farhad Hafezi, MD, PhD, FARVO, Medical Director of the ELZA Institute, published in the November/December issue of Cataract and Refractive Surgery
The 18th CXL Experts’ Meeting, led by ELZA’s CMO, Prof. Farhad Hafezi, was held last weekend in Zurich, Switzerland.
This month’s issue of Ophthalmology Times Europe saw the publication of a review article, “The pathophysiology and pathomorphology of corneal ectasia” authored by Prof. Hafezi, Medical Director of the ELZA Institute, and Dr. Omid Kermani, Managing Director at Augenklinik am Neumarkt in Cologne.
ELZA’s Medical Director, Prof. Farhad Hafezi has returned from Antalya, Turkey, where he gave a lecture entitled “Frontiers in Cross-Linking in Keratoconus” to the delegates of the
The advantages of performing corneal cross-linking (CXL) at the slit lamp are well established. It brings CXL out of the operating theater, to anywhere where
